Original paper
Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis
Abstract
In the present study, the objective was to attain a localized lung delivery of an anti-tubercular fluoroquinolone, moxifloxacin (MXF), targeting the alveolar macrophages through a non-invasive pulmonary route using inhalable microspheres as a dry powder inhaler approach. MXF-loaded poly (lactic-co-glycolic acid) (PLGA) microspheres (MXF-PLGA-MSs) were fabricated by solvent evaporation technique and optimized by using a central composite...
Paper Details
Title
Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis
Published Date
Jan 8, 2021
Journal
Volume
13
Issue
1
Pages
79 - 79